Natural Resources - Riverine Siting and Design Criteria - Requirements
HB0779 authorizes the Department of Public Safety and Correctional Services to establish a medication review committee to decide whether psychotropic medication may be administered over the objection of an incarcerated individual in a State correctional facility. The bill applies only to State correctional facilities and sets out a detailed process for nonemergency involuntary medication when an incarcerated person refuses prescribed psychotropic medication, including clinical findings that must be made before medication can be approved.
The bill creates a formal committee process with specified membership, including psychiatrists and a nonphysician mental health professional, and requires an impartial lay advisor to help the incarcerated individual understand the process. It also requires advance written notice, the right to attend the hearing, present evidence and witnesses, ask questions, and receive information about diagnosis, treatment need, and risks and benefits. The committee must review a detailed report from the treating provider, make a written decision, and allow administrative review by the Clinical Services Management Team. Approvals are limited to 90 days, with renewal procedures and ongoing documentation requirements for benefits and side effects.
HB0779 would add a new section to the Correctional Services Article, creating a statutory framework for involuntary psychotropic medication decisions in Maryland State correctional facilities. It would establish procedural safeguards, documentation duties, review timelines, and appeal rights, while also authorizing correctional health officials to override refusal of medication in emergencies or after committee approval in nonemergency cases. The bill would directly affect incarcerated individuals receiving mental health treatment, correctional medical staff, psychiatrists, and Department of Public Safety and Correctional Services administrators.
The available context shows the bill was introduced as a departmental measure by the Public Safety and Correctional Services agency and referred to the Judiciary Committee, with no recorded votes or committee testimony provided. Based on the text, the bill appears to reflect a policy effort to formalize and constrain an existing clinical process rather than to expand correctional authority without limits. The overall tone is procedural and protective, emphasizing due process, clinical review, and documentation.
The main point of contention is the balance between inmate autonomy and institutional authority to administer psychotropic medication without consent. Supporters would likely emphasize the bill’s safeguards, including notice, lay advisor assistance, committee review, and administrative appeal, while critics may focus on the power to medicate over objection and the potential for coercion in a correctional setting. Another likely area of concern is whether the standards for “serious harm,” clinical necessity, and emergency use are sufficiently clear and whether the review process is independent enough from treating staff.